KRAS and thyroid gland carcinoma: The results revealed significant increases in the expression of BRAF, EIF1 AX, KRAS, PIK3 CA, and TERT genes across all types of immune cells in thyroid cancer, indicating their variability and potential regulatory roles in the immune microenvironment (Fig. 8).